HuBei NengTer Technology CO.,Ltd (SHE:002102)
China · Delayed Price · Currency is CNY 2.340
+0.080 (3.54%)
Aug 26, 2026, 3:04 PM CST
SHE:002102 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 5,293 | 7,272 | 10,262 | 11,129 | 12,260 | 13,533 |
Revenue Growth | -39.17% | -29.14% | -7.79% | -9.23% | -9.40% | 5.38% |
Gross Profit Gross Profit Growth | 204.43 | 136.87 | 208.18 | 278.78 | 360.75 | 441.14 |
Operating Income Operating Income Growth | 44.86 | -9.86 | 4.88 | 88.69 | 154.83 | 231.11 |
Net Income Net Income Growth | -5.1 | 248.45 | -600.17 | 258.74 | 444.48 | 101.09 |
Earnings Per Share EPS Growth | -0.00 | 0.10 | -0.23 | 0.10 | 0.17 | 0.04 |
EPS Growth | - | - | - | -41.83% | 339.58% | -19.50% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Pharmaceutical and Chemical Engineering Pharmaceutical and Chemical Engineering Growth | 853.45 | 1,061 |
Trade Business Trade Business Growth | 6,390 | 9,158 |
Materials for Sale Materials for Sale Growth | 5.49 | 5.78 |
Park Operation and Others Park Operation and Others Growth | 23.42 | 36.54 |
Total Total Growth | 7,272 | 10,262 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 797.55 | 998.57 | 1,923 | 2,121 | 1,827 | 1,340 |
Total Debt Total Debt Growth | 1,140 | 1,313 | 1,339 | 1,524 | 1,849 | 1,386 |
Net Cash (Debt) Net Cash Growth | -342.24 | -314.54 | 583.57 | 597.63 | -21.75 | -46.33 |
Net Cash Growth | - | - | -2.35% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.14 | -0.13 | 0.22 | 0.23 | -0.01 | -0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -857.42 | -315.3 | 92.01 | 812.57 | -738.52 | 240.21 |
Capital Expenditures CapEx Growth | -176.79 | -132.55 | -94.54 | -30.11 | -155.96 | -211.89 |
Free Cash Flow Free Cash Flow Growth | -1,034 | -447.85 | -2.53 | 782.46 | -894.48 | 28.32 |
Free Cash Flow Growth | - | - | - | - | - | -96.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 3.86% | 1.88% | 2.03% | 2.50% | 2.94% | 3.26% |
Operating Margin | 0.85% | -0.14% | 0.05% | 0.80% | 1.26% | 1.71% |
Pretax Margin | 0.33% | 3.58% | -6.34% | 2.69% | 4.13% | 1.39% |
Profit Margin | -0.10% | 3.42% | -5.85% | 2.33% | 3.62% | 0.75% |
FCF Margin | -19.54% | -6.16% | -0.03% | 7.03% | -7.30% | 0.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 32.72 | - | 27.57 | 18.48 | 102.61 |
Forward PE | - | 12.81 | 7.27 | 7.27 | 7.27 | 7.27 |
P/FCF Ratio | - | - | - | 9.12 | - | 366.24 |
PS Ratio | 1.04 | 1.12 | 0.67 | 0.64 | 0.67 | 0.77 |